Taiho Oncology, Inc. maintains a specialized global workforce numbering approximately 600 full-time professional employees. Its personnel are distributed across administrative operations, clinical research, regulatory affairs, and commercial divisions primarily located in North America and international subsidiaries, supporting the advancement and commercialization of its portfolio of oral anticancer medications.